李帅 博士后(2015-2017)

 

E-mail:  lishuai910@163.com

 教育经历

2011.07 – 2014.07 北京大学，基础医学院，博士

2009.09 – 2011.07 北京大学，基础医学院，硕士

 

工作经历

2015.07 – 至今 北京大学，天然药物与仿生药物国家重点实验室，博后

研究领域

肿瘤转移的分子生物学机制研究；新的肿瘤治疗靶点的发掘；肿瘤的基因治疗

代表性论文

1.          Chang Liu^#, Shuai Li^#, et al. PRC2 regulates RNA polymerase III transcribed noncoding RNA gene transcription through EZH2 and SUZ12 interaction with TFIIIC complex. Nuleic Acids Reserach, 2015. In press. Co-first author.

2.          Junhu Wan, Jun Zhan, Shuai Li, Ji Ma, Chang Liu, Xiaowei Xue, Yuping Xie, Weigang Fang, Y.Eugene Chin, Hongquan Zhang. PCAF-primed EZH2 acetylation regulates its stability and promotes lung adenocarcinoma progression. Nucleic Acids Research, 2015 Apr 20;43(7):3591-604.

3.          Jun Zhan, Miaomiao Niu, Peng Wang, Xiang Zhu, Shuai Li, Jiagui Song, Huiying He, Yunling Wang, Lixiang Xue, Weigang Fang, Hongquan Zhang. Elevated HOXB9 expression promotes differentiation and predicts a favorable outcome in colon adenocarcinoma patients. British Journal of Cancer 2014 Aug 26;111, 883-893.